| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-13 09:06 Tx date 2026-03-11 |
$ONCY
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,300
+10,000 vol $1.03 each |
41,849 | |
| Filed 2026-03-04 11:28 Tx date 2026-03-03 |
$SVA
Sernova Biotherapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-30,000
-100,000 vol $0.30 each |
0 | |
| Filed 2026-02-27 15:33 Tx date 2026-02-24 |
$SVA
Sernova Biotherapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$90,000
+600,000 vol $0.15 each |
7,320,000 | |
| Filed 2026-02-27 15:31 Tx date 2026-02-24 |
$SVA
Sernova Biotherapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$120,000
+400,000 vol $0.30 each |
6,720,000 | |
| Filed 2026-02-27 15:30 Tx date 2026-02-24 |
$SVA
Sernova Biotherapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$187,500
+1,250,000 vol $0.15 each |
6,320,000 | |
| Filed 2025-08-22 18:29 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$162,000
+150,000 vol $1.08 each |
255,000 | |
| Filed 2025-07-16 19:02 Tx date 2025-07-16 |
$ONC
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+23,746 vol |
31,849 | |
| Filed 2025-07-16 19:01 Tx date 2025-07-16 |
$ONC
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-23,746 vol |
0 | |
| Filed 2025-07-16 19:00 Tx date 2025-07-14 |
$ONC
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+23,746 vol |
23,746 | |
| Filed 2025-06-04 11:31 Tx date 2025-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,739 vol |
101,388 | |
| Filed 2025-04-22 18:38 Tx date 2025-04-21 |
$ONC
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,103 vol |
8,103 | |
| Filed 2025-04-22 18:37 Tx date 2022-06-16 |
$ONC
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-04-22 18:36 Tx date 2025-04-21 |
$ONC
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-23,255 vol |
0 | |
| Filed 2025-04-04 17:45 Tx date 2025-03-31 |
$ONC
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+23,255 vol |
23,255 | |
| Filed 2025-04-04 17:44 Tx date 2022-06-16 |
$ONC
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-12-20 16:56 Tx date 2024-12-18 |
$ONC
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$33,900
+30,000 vol $1.13 each |
105,000 | |
| Filed 2024-10-29 15:14 Tx date 2024-10-22 |
$SVA
Sernova Corp. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,170,000
+4,500,000 vol $0.26 each |
5,070,000 | |
| Filed 2024-10-29 15:12 Tx date 2024-10-22 |
$SVA
Sernova Corp. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Rights Share appreciation rights
38 - Redemption, retraction, cancellation, repurchase
|
-4,500,000 vol |
0 | |
| Filed 2024-10-11 15:42 Tx date 2024-10-07 |
$SVA
Sernova Corp. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Rights Share appreciation rights
56 - Grant of rights
|
$1,170,000
+4,500,000 vol $0.26 each |
4,500,000 | |
| Filed 2024-10-11 15:38 Tx date 2012-04-19 |
$SVA
Sernova Corp. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Rights Share appreciation rights
00 - Opening Balance-Initial SEDI Report
|